Patents Assigned to Apex Therapeutics, Inc.
  • Quinone compounds for treating Ape1 mediated diseases
    Patent number: 9193700
    Abstract: The invention described herein pertains to compounds and compositions for treating Ape1 mediated diseases. In particular, the invention described herein pertains to quinone compounds and pharmaceutical compositions containing them for treating Ape1 mediated diseases.
    Type: Grant
    Filed: May 25, 2012
    Date of Patent: November 24, 2015
    Assignees: Indiana University Research and Technology Corporation, Apex Therapeutics, Inc.
    Inventors: Mark R. Kelley, James H. Wikel